APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadolinium-Based Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gadolinium-Based Contrast Agents Market Outlook and Growth Opportunities 2026

31 December 2025194 pages

Choose your research edition.

Industry ResearchGadolinium-Based Contrast Agents Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadolinium-Based Contrast Agents Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Gadolinium-Based Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadolinium-Based Contrast Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadolinium-Based Contrast Agents Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gadolinium-Based Contrast Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadolinium-Based Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gadolinium-Based Contrast Agents market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gadolinium-Based Contrast Agents market include Agfa, BeiLu Pharma, Bracco Imaging, GE Healthcare, Guerbet Group, Hengrui Medicine, Lantheus, Marotrast and YRPG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gadolinium-Based Contrast Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gadolinium-Based Contrast Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gadolinium-Based Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadolinium-Based Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Gadolinium-Based Contrast Agents Segment by Company

Agfa

BeiLu Pharma

Bracco Imaging

GE Healthcare

Guerbet Group

Hengrui Medicine

Lantheus

Marotrast

YRPG

Bayer

Jiangsu Hengrui Medicine

Stary

Gadolinium-Based Contrast Agents Segment by Type

Linear Gadolinium-Based Contrast Agents

Macrocycle Gadolinium-Based Contrast Agents

Gadolinium-Based Contrast Agents Segment by Application

Hospital

Specialist Clinic

Others

Gadolinium-Based Contrast Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Gadolinium-Based Contrast Agents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gadolinium-Based Contrast Agents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gadolinium-Based Contrast Agents significant trends, drivers, influence factors in global and regions.

6. To analyze Gadolinium-Based Contrast Agents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadolinium-Based Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadolinium-Based Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadolinium-Based Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gadolinium-Based Contrast Agents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gadolinium-Based Contrast Agents industry.

Chapter 3: Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gadolinium-Based Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gadolinium-Based Contrast Agents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gadolinium-Based Contrast Agents Industry Trends Table 2. Gadolinium-Based Contrast Agents Industry Drivers Table 3. Gadolinium-Based Contrast Agents Industry Opportunities and Challenges Table 4. Gadolinium-Based Contrast Agents Industry Restraints Table 5. Global Gadolinium-Based Contrast Agents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gadolinium-Based Contrast Agents Revenue Share by Company (2021-2026) Table 7. Global Gadolinium-Based Contrast Agents Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Gadolinium-Based Contrast Agents Sales Volume Share by Company (2021-2026) Table 9. Global Gadolinium-Based Contrast Agents Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Gadolinium-Based Contrast Agents Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gadolinium-Based Contrast Agents Key Company Manufacturing Base & Headquarters Table 12. Global Gadolinium-Based Contrast Agents Company, Product Type & Application Table 13. Global Gadolinium-Based Contrast Agents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gadolinium-Based Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Linear Gadolinium-Based Contrast Agents Table 18. Significant Companies of Macrocycle Gadolinium-Based Contrast Agents Table 19. Global Gadolinium-Based Contrast Agents Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gadolinium-Based Contrast Agents Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Gadolinium-Based Contrast Agents Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Gadolinium-Based Contrast Agents Sales Volume Share by Type (2021-2026) Table 23. Global Gadolinium-Based Contrast Agents Sales Volume Share by Type (2027-2032) Table 24. Global Gadolinium-Based Contrast Agents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gadolinium-Based Contrast Agents Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Gadolinium-Based Contrast Agents Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Gadolinium-Based Contrast Agents Sales Value Share by Type (2021-2026) Table 28. Global Gadolinium-Based Contrast Agents Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Specialist Clinic Table 31. Significant Companies of Others Table 32. Global Gadolinium-Based Contrast Agents Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Gadolinium-Based Contrast Agents Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Gadolinium-Based Contrast Agents Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Gadolinium-Based Contrast Agents Sales Volume Share by Application (2021-2026) Table 36. Global Gadolinium-Based Contrast Agents Sales Volume Share by Application (2027-2032) Table 37. Global Gadolinium-Based Contrast Agents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Gadolinium-Based Contrast Agents Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Gadolinium-Based Contrast Agents Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Gadolinium-Based Contrast Agents Sales Value Share by Application (2021-2026) Table 41. Global Gadolinium-Based Contrast Agents Sales Value Share by Application (2027-2032) Table 42. Global Gadolinium-Based Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Gadolinium-Based Contrast Agents Sales by Region (2021-2026) & (K Units) Table 44. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2021-2026) Table 45. Global Gadolinium-Based Contrast Agents Sales by Region (2027-2032) & (K Units) Table 46. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2027-2032) Table 47. Global Gadolinium-Based Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gadolinium-Based Contrast Agents Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Gadolinium-Based Contrast Agents Sales Value Share by Region (2021-2026) Table 50. Global Gadolinium-Based Contrast Agents Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Gadolinium-Based Contrast Agents Sales Value Share by Region (2027-2032) Table 52. Global Gadolinium-Based Contrast Agents Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Gadolinium-Based Contrast Agents Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Gadolinium-Based Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Gadolinium-Based Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Gadolinium-Based Contrast Agents Sales by Country (2021-2026) & (K Units) Table 57. Global Gadolinium-Based Contrast Agents Sales Market Share by Country (2021-2026) Table 58. Global Gadolinium-Based Contrast Agents Sales by Country (2027-2032) & (K Units) Table 59. Global Gadolinium-Based Contrast Agents Sales Market Share by Country (2027-2032) Table 60. Global Gadolinium-Based Contrast Agents Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Gadolinium-Based Contrast Agents Sales Value Market Share by Country (2021-2026) Table 62. Global Gadolinium-Based Contrast Agents Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Gadolinium-Based Contrast Agents Sales Value Market Share by Country (2027-2032) Table 64. Agfa Company Information Table 65. Agfa Business Overview Table 66. Agfa Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Agfa Gadolinium-Based Contrast Agents Product Portfolio Table 68. Agfa Recent Development Table 69. BeiLu Pharma Company Information Table 70. BeiLu Pharma Business Overview Table 71. BeiLu Pharma Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio Table 73. BeiLu Pharma Recent Development Table 74. Bracco Imaging Company Information Table 75. Bracco Imaging Business Overview Table 76. Bracco Imaging Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio Table 78. Bracco Imaging Recent Development Table 79. GE Healthcare Company Information Table 80. GE Healthcare Business Overview Table 81. GE Healthcare Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio Table 83. GE Healthcare Recent Development Table 84. Guerbet Group Company Information Table 85. Guerbet Group Business Overview Table 86. Guerbet Group Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio Table 88. Guerbet Group Recent Development Table 89. Hengrui Medicine Company Information Table 90. Hengrui Medicine Business Overview Table 91. Hengrui Medicine Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio Table 93. Hengrui Medicine Recent Development Table 94. Lantheus Company Information Table 95. Lantheus Business Overview Table 96. Lantheus Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Lantheus Gadolinium-Based Contrast Agents Product Portfolio Table 98. Lantheus Recent Development Table 99. Marotrast Company Information Table 100. Marotrast Business Overview Table 101. Marotrast Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Marotrast Gadolinium-Based Contrast Agents Product Portfolio Table 103. Marotrast Recent Development Table 104. YRPG Company Information Table 105. YRPG Business Overview Table 106. YRPG Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. YRPG Gadolinium-Based Contrast Agents Product Portfolio Table 108. YRPG Recent Development Table 109. Bayer Company Information Table 110. Bayer Business Overview Table 111. Bayer Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Bayer Gadolinium-Based Contrast Agents Product Portfolio Table 113. Bayer Recent Development Table 114. Jiangsu Hengrui Medicine Company Information Table 115. Jiangsu Hengrui Medicine Business Overview Table 116. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio Table 118. Jiangsu Hengrui Medicine Recent Development Table 119. Stary Company Information Table 120. Stary Business Overview Table 121. Stary Gadolinium-Based Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Stary Gadolinium-Based Contrast Agents Product Portfolio Table 123. Stary Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Gadolinium-Based Contrast Agents Distributors List Table 127. Gadolinium-Based Contrast Agents Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Gadolinium-Based Contrast Agents Product Image Figure 2. Global Gadolinium-Based Contrast Agents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadolinium-Based Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gadolinium-Based Contrast Agents Sales (2021-2032) & (K Units) Figure 5. Global Gadolinium-Based Contrast Agents Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Gadolinium-Based Contrast Agents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Linear Gadolinium-Based Contrast Agents Image Figure 10. Macrocycle Gadolinium-Based Contrast Agents Image Figure 11. Global Gadolinium-Based Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Gadolinium-Based Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Gadolinium-Based Contrast Agents Sales Volume Share by Type (2021-2032) Figure 14. Global Gadolinium-Based Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Gadolinium-Based Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Gadolinium-Based Contrast Agents Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Specialist Clinic Image Figure 19. Others Image Figure 20. Global Gadolinium-Based Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Gadolinium-Based Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Gadolinium-Based Contrast Agents Sales Volume Share by Application (2021-2032) Figure 23. Global Gadolinium-Based Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Gadolinium-Based Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Gadolinium-Based Contrast Agents Sales Value Share by Application (2021-2032) Figure 26. Global Gadolinium-Based Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Gadolinium-Based Contrast Agents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Gadolinium-Based Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Gadolinium-Based Contrast Agents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Gadolinium-Based Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 31. North America Gadolinium-Based Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Gadolinium-Based Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Gadolinium-Based Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Gadolinium-Based Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Gadolinium-Based Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Gadolinium-Based Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 37. South America Gadolinium-Based Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Gadolinium-Based Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Gadolinium-Based Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Gadolinium-Based Contrast Agents Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Gadolinium-Based Contrast Agents Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Linear Gadolinium-Based Contrast Agents
  • Macrocycle Gadolinium-Based Contrast Agents
Applications
  • Hospital
  • Specialist Clinic
  • Others
Companies covered
  • Agfa
  • BeiLu Pharma
  • Bracco Imaging
  • GE Healthcare
  • Guerbet Group
  • Hengrui Medicine
  • Lantheus
  • Marotrast
  • YRPG
  • Bayer
  • Jiangsu Hengrui Medicine
  • Stary

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gadolinium-Based Contrast Agents Sales Value (2021-2032)
  4. 1.2.2 Global Gadolinium-Based Contrast Agents Sales Volume (2021-2032)
  5. 1.2.3 Global Gadolinium-Based Contrast Agents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gadolinium-Based Contrast Agents Market Dynamics
  1. 2.1 Gadolinium-Based Contrast Agents Industry Trends
  2. 2.2 Gadolinium-Based Contrast Agents Industry Drivers
  3. 2.3 Gadolinium-Based Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Gadolinium-Based Contrast Agents Industry Restraints
3 Gadolinium-Based Contrast Agents Market by Company
  1. 3.1 Global Gadolinium-Based Contrast Agents Company Revenue Ranking in 2025
  2. 3.2 Global Gadolinium-Based Contrast Agents Revenue by Company (2021-2026)
  3. 3.3 Global Gadolinium-Based Contrast Agents Sales Volume by Company (2021-2026)
  4. 3.4 Global Gadolinium-Based Contrast Agents Average Price by Company (2021-2026)
  5. 3.5 Global Gadolinium-Based Contrast Agents Company Ranking (2024-2026)
  6. 3.6 Global Gadolinium-Based Contrast Agents Company Manufacturing Base and Headquarters
  7. 3.7 Global Gadolinium-Based Contrast Agents Company Product Type and Application
  8. 3.8 Global Gadolinium-Based Contrast Agents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gadolinium-Based Contrast Agents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gadolinium-Based Contrast Agents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gadolinium-Based Contrast Agents Market by Type
  1. 4.1 Gadolinium-Based Contrast Agents Type Introduction
  2. 4.1.1 Linear Gadolinium-Based Contrast Agents
  3. 4.1.2 Macrocycle Gadolinium-Based Contrast Agents
  4. 4.2 Global Gadolinium-Based Contrast Agents Sales Volume by Type
  5. 4.2.1 Global Gadolinium-Based Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gadolinium-Based Contrast Agents Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Gadolinium-Based Contrast Agents Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Gadolinium-Based Contrast Agents Sales Value by Type
  9. 4.3.1 Global Gadolinium-Based Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gadolinium-Based Contrast Agents Sales Value by Type (2021-2032)
  11. 4.3.3 Global Gadolinium-Based Contrast Agents Sales Value Share by Type (2021-2032)
5 Gadolinium-Based Contrast Agents Market by Application
  1. 5.1 Gadolinium-Based Contrast Agents Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Specialist Clinic
  4. 5.1.3 Others
  5. 5.2 Global Gadolinium-Based Contrast Agents Sales Volume by Application
  6. 5.2.1 Global Gadolinium-Based Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gadolinium-Based Contrast Agents Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gadolinium-Based Contrast Agents Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gadolinium-Based Contrast Agents Sales Value by Application
  10. 5.3.1 Global Gadolinium-Based Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gadolinium-Based Contrast Agents Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gadolinium-Based Contrast Agents Sales Value Share by Application (2021-2032)
6 Gadolinium-Based Contrast Agents Regional Sales and Value Analysis
  1. 6.1 Global Gadolinium-Based Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gadolinium-Based Contrast Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Gadolinium-Based Contrast Agents Sales by Region: 2021-2026
  4. 6.2.2 Global Gadolinium-Based Contrast Agents Sales by Region (2027-2032)
  5. 6.3 Global Gadolinium-Based Contrast Agents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gadolinium-Based Contrast Agents Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gadolinium-Based Contrast Agents Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gadolinium-Based Contrast Agents Sales Value by Region (2027-2032)
  9. 6.5 Global Gadolinium-Based Contrast Agents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gadolinium-Based Contrast Agents Sales Value (2021-2032)
  12. 6.6.2 North America Gadolinium-Based Contrast Agents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gadolinium-Based Contrast Agents Sales Value (2021-2032)
  15. 6.7.2 Europe Gadolinium-Based Contrast Agents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gadolinium-Based Contrast Agents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gadolinium-Based Contrast Agents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gadolinium-Based Contrast Agents Sales Value (2021-2032)
  21. 6.9.2 South America Gadolinium-Based Contrast Agents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gadolinium-Based Contrast Agents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gadolinium-Based Contrast Agents Sales Value Share by Country, 2025 VS 2032
7 Gadolinium-Based Contrast Agents Country-level Sales and Value Analysis
  1. 7.1 Global Gadolinium-Based Contrast Agents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gadolinium-Based Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gadolinium-Based Contrast Agents Sales by Country (2021-2032)
  4. 7.3.1 Global Gadolinium-Based Contrast Agents Sales by Country (2021-2026)
  5. 7.3.2 Global Gadolinium-Based Contrast Agents Sales by Country (2027-2032)
  6. 7.4 Global Gadolinium-Based Contrast Agents Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gadolinium-Based Contrast Agents Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gadolinium-Based Contrast Agents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gadolinium-Based Contrast Agents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gadolinium-Based Contrast Agents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gadolinium-Based Contrast Agents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agfa
  2. 8.1.1 Agfa Company Information
  3. 8.1.2 Agfa Business Overview
  4. 8.1.3 Agfa Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Agfa Gadolinium-Based Contrast Agents Product Portfolio
  6. 8.1.5 Agfa Recent Developments
  7. 8.2 BeiLu Pharma
  8. 8.2.1 BeiLu Pharma Company Information
  9. 8.2.2 BeiLu Pharma Business Overview
  10. 8.2.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BeiLu Pharma Gadolinium-Based Contrast Agents Product Portfolio
  12. 8.2.5 BeiLu Pharma Recent Developments
  13. 8.3 Bracco Imaging
  14. 8.3.1 Bracco Imaging Company Information
  15. 8.3.2 Bracco Imaging Business Overview
  16. 8.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bracco Imaging Gadolinium-Based Contrast Agents Product Portfolio
  18. 8.3.5 Bracco Imaging Recent Developments
  19. 8.4 GE Healthcare
  20. 8.4.1 GE Healthcare Company Information
  21. 8.4.2 GE Healthcare Business Overview
  22. 8.4.3 GE Healthcare Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GE Healthcare Gadolinium-Based Contrast Agents Product Portfolio
  24. 8.4.5 GE Healthcare Recent Developments
  25. 8.5 Guerbet Group
  26. 8.5.1 Guerbet Group Company Information
  27. 8.5.2 Guerbet Group Business Overview
  28. 8.5.3 Guerbet Group Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Guerbet Group Gadolinium-Based Contrast Agents Product Portfolio
  30. 8.5.5 Guerbet Group Recent Developments
  31. 8.6 Hengrui Medicine
  32. 8.6.1 Hengrui Medicine Company Information
  33. 8.6.2 Hengrui Medicine Business Overview
  34. 8.6.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
  36. 8.6.5 Hengrui Medicine Recent Developments
  37. 8.7 Lantheus
  38. 8.7.1 Lantheus Company Information
  39. 8.7.2 Lantheus Business Overview
  40. 8.7.3 Lantheus Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lantheus Gadolinium-Based Contrast Agents Product Portfolio
  42. 8.7.5 Lantheus Recent Developments
  43. 8.8 Marotrast
  44. 8.8.1 Marotrast Company Information
  45. 8.8.2 Marotrast Business Overview
  46. 8.8.3 Marotrast Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Marotrast Gadolinium-Based Contrast Agents Product Portfolio
  48. 8.8.5 Marotrast Recent Developments
  49. 8.9 YRPG
  50. 8.9.1 YRPG Company Information
  51. 8.9.2 YRPG Business Overview
  52. 8.9.3 YRPG Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 YRPG Gadolinium-Based Contrast Agents Product Portfolio
  54. 8.9.5 YRPG Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bayer Gadolinium-Based Contrast Agents Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 Jiangsu Hengrui Medicine
  62. 8.11.1 Jiangsu Hengrui Medicine Company Information
  63. 8.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 8.11.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product Portfolio
  66. 8.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 8.12 Stary
  68. 8.12.1 Stary Company Information
  69. 8.12.2 Stary Business Overview
  70. 8.12.3 Stary Gadolinium-Based Contrast Agents Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Stary Gadolinium-Based Contrast Agents Product Portfolio
  72. 8.12.5 Stary Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gadolinium-Based Contrast Agents Value Chain Analysis
  2. 9.1.1 Gadolinium-Based Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gadolinium-Based Contrast Agents Sales Mode & Process
  6. 9.2 Gadolinium-Based Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gadolinium-Based Contrast Agents Distributors
  9. 9.2.3 Gadolinium-Based Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst